If you think the 2026 market is all about big tech and AI datacenters, you aren't paying attention. Look further down the food chain, and you'll find a bizarre reality fueled by buzzword bingo, desperate reverse splits, and sheer survival tactics. These 10 companies are doing whatever it takes to stay relevant. Let's call it what it is: a sideshow.

The Buzzword Bingo Players

Top Win International Limited (SORA.US) used to sell luxury watches in Hong Kong. Now, they've renamed themselves AsiaStrategy, started accepting Bitcoin, and grabbed the ticker 'SORA'. This is stupid and here's why: slapping crypto onto a retail watch business is the oldest trick in the book to mask mediocre fundamentals.

YY Group Holding (YYGH.US) just executed a 1-for-30 reverse stock split to avoid being booted off the Nasdaq. Their next brilliant move? Announcing a "commercial humanoid robot" program to solve facility management shortages. Using sci-fi narratives to distract from a reverse split? Good luck with that.

Then we have Rocket One (RKTO.US), an "AI infrastructure" company that just tossed every hot keyword into a blender: smart edge computing, Swarm Stage AI to combat drones, and a SpaceXAI API. They are sitting on about USD 8.4M in cash as of mid-2026. Why aren't you moving faster to build a real product instead of churning out press releases?

At least GCL Global Holdings (GCL.US) is actually releasing something tangible. They are launching martial arts RPGs and just secured an expanded strategic investment from ADATA. Gaming is brutal, but at least they aren't pretending to be an AI robotics firm.

The Hangovers and The Dinosaurs

Novavax (NVAX.US) is suffering a massive hangover. Q1 2026 revenue plummeted 79.1% year-over-year to USD 139.5M. The pandemic is over, the vaccine market has moved on, and sitting around hoping for a revival is not a strategy.

Dragonfly Energy (DFLI.US) loves to tout its new US and European patents for solid-state batteries. That’s cute, but Q1 2026 net sales dropped 27.3% to USD 9.7M. Patents don't pay the bills; commercialization does.

And yes, Xerox Holdings (XRX.US) is still alive. STARTEEPO Invest recently upped its stake to over 6%. Remind me again who is heavily relying on printers in 2026? But hey, they continue to pay out dividends, so someone out there is happy.

Over in the travel sector, Norwegian Cruise Line (NCLH.US) is hyping up its wellness cruises ahead of its Q2 2026 earnings call. Options data points to a potential 7.3% post-earnings swing. The post-COVID revenge travel narrative is getting stale; they need to show real margin growth now.

Universe Pharmaceuticals (UPC.US) is another reverse split frequent flyer (6-for-1, 15-for-1, and 40-for-1). They recently bought Best Praise International for USD 10.7M in stock to acquire five patents. We've seen this capital shell game before.

Even a giant like Hershey (HSY.US) isn't immune to macro headwinds. Cocoa costs have skyrocketed exponentially, forcing them to raise prices. The difference? You'll still buy their newly launched Reese's Pieces chocolate chip cookies anyway.

My view is simple: investing in the fringes of the market is like dumpster diving. You might find a hidden gem, but most of it is just trash waiting to be taken out. For those companies addicted to ticker changes, buzzwords, and reverse splits, the best strategy is to stand back and watch how long they can keep up the charade in a 2026 market that has finally remembered how to do math.

This article does not constitute investment advice.